Skip to product information
1 of 1

BT Lab

LXRAlpha Polyclonal Antibody - BT-AP05117

LXRAlpha Polyclonal Antibody - BT-AP05117

Regular price $151.20 CAD
Regular price Sale price $151.20 CAD
Sale Sold out
Size
Quantity

Get a quote

LXRAlpha Polyclonal Antibody

Sizes: 20μL, 50μL, 100μL

Catalogue Numbers: BT-AP05117-20, BT-AP05117-50, BT-AP05117-100

Citations, Manuals and MSDS Available upon request.

Background: Oxysterols receptor LXR-alpha encoded by NR1H3 belongs to the NR1 subfamily of the nuclear receptor superfamily. The NR1 family members are key regulators of macrophage function, controlling transcriptional programs involved in lipid homeostasis and inflammation. This protein is highly expressed in visceral organs, including liver, kidney and intestine. It forms a heterodimer with retinoid X receptor (RXR), and regulates expression of target genes containing retinoid response elements. Studies in mice lacking this gene suggest that it may play an important role in the regulation of cholesterol homeostasis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Research Areas: Cardiovascular

Target Protein: NR1H3

Applications: WB, IHC-p, ELISA

Reactivity: Human, Mouse, Rat

Clonality: Polyclonal

Host: Rabbit

Isotype: IgG

Full Product Name: LXRalpha Antibody

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Storage: -20°C for 1 year

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

Molecular Weight (Da): 50396

UniProt Accession: Human: Q13133; Mouse: Q9Z0Y9; Rat: Q62685

Synonyms: NR1H3; LXRA; Oxysterols receptor LXR-alpha; Liver X receptor alpha; Nuclear receptor subfamily 1 group H member 3

GeneID: Human: 10062; Mouse: 22259

Research Use Only

View full details